Treatment and Prevention of Enteric Infections With Toxin-binding Probiotics

Simple item page
dc.contributor.authorPaton, A.
dc.contributor.authorMorona, R.
dc.contributor.authorPaton, J.
dc.date.issued2006
dc.description.abstractNearly all antibiotics aim at killing the bacteria, which eventually develop antibiotic resistance under ‘survival pressure’. The pathology exerted by many pathologic bacteria is through secreting toxins. Probiotics, either harmless live bacteria or dead ones, can be molecularly engineered to express receptors for the toxins and absorb and eliminate them from binding to their natural receptors, thus reducing or eliminating the pathological impact of bacterial infection.
dc.description.statementofresponsibilityAdrienne W. Paton, Renato Morona, and James C. Paton
dc.identifier.citationDISCOVERY MEDICINE, 2006; 6(31):35-39
dc.identifier.issn1539-6509
dc.identifier.issn1944-7930
dc.identifier.orcidMorona, R. [0000-0001-7009-7440]
dc.identifier.orcidPaton, J. [0000-0001-9807-5278]
dc.identifier.urihttp://hdl.handle.net/2440/34815
dc.language.isoen
dc.publisherSolariz, Inc.
dc.source.urihttp://www.discoverymedicine.com/ViewAbstract.php?rec=10409214446231373311193
dc.subjectAnimals
dc.subjectHumans
dc.subjectBacterial Infections
dc.subjectGastrointestinal Diseases
dc.subjectBacterial Toxins
dc.subjectModels, Biological
dc.subjectProbiotics
dc.titleTreatment and Prevention of Enteric Infections With Toxin-binding Probiotics
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Molecular and Biomedical Science publications